The research lab led by Hanzhang Lu at Johns Hopkins University focuses on understanding the vascular contributions to cognitive impairment and dementia, particularly small-vessel-related conditions. They work on developing and validating biomarkers that can help in the diagnosis and treatment of various types of dementia, including Alzheimer's disease. Their pioneering work includes using advanced MRI techniques to measure brain physiology, aiming to improve patient care through better diagnostic tools.

Dr. Zhiliang Wei's lab at Johns Hopkins University focuses on understanding how reduced blood flow in the brain, known as hypoperfusion, affects Alzheimer's disease and related dementias. By using advanced MRI techniques and mouse models, the lab aims to explore how blood flow interacts with brain metabolism and cognitive functions. This research is crucial for identifying new biomarkers and treatments for dementia, enhancing the understanding of the disease mechanisms.

Dr. Tzyy-Choou Wu's lab focuses on developing effective cancer vaccines specifically for cervical cancer caused by human papillomavirus (HPV). They are investigating how different genetic variants of HPV can evade the immune system and impact cancer growth. The lab aims to create a therapeutic vaccine that works for diverse populations, addressing disparities in cervical cancer outcomes around the world.

Professor Jeffery Coller's lab at Johns Hopkins University studies the role of codon optimality in determining the stability of messenger RNA (mRNA). By investigating how the rates at which ribosomes decode mRNA influence its degradation, the lab aims to uncover critical principles of gene regulation. Their research has implications for understanding cancer and viral infections, as these processes can disrupt normal cellular functions and exploit the mechanisms of gene expression.

Dr. Isabelle Coppens leads a research lab at Johns Hopkins University that focuses on understanding how the Toxoplasma gondii parasite survives inside host cells. Her team investigates the ways in which this parasite hijacks lipid transport mechanisms from mammalian cells, allowing it to acquire essential nutrients for survival. This research has implications for developing treatments against Toxoplasma and enhancing our understanding of cellular processes.

Dr. Arturo Casadevall's lab at Johns Hopkins University focuses on understanding the biology of Cryptococcus neoformans, a dangerous fungal pathogen. The lab investigates how this fungus produces melanin, which helps it evade the immune system and resist antifungal treatments. By studying this process, the lab aims to develop new drugs and diagnostic tools to treat infections caused by drug-resistant fungi, ultimately improving health outcomes for people, especially those with weakened immune systems.

Dr. Kathleen E. Cullen's lab at Johns Hopkins University focuses on understanding how the brain processes balance and motion through the vestibular system, which is crucial for maintaining stability and clear vision. The lab's research aims to uncover the mechanisms by which the cerebellum helps the brain differentiate between self-generated and external motion effects. Additionally, they are working on developing innovative treatments like vestibular prostheses to assist individuals who have lost their balance sensations due to disease or aging.

George Dimopoulos's research lab at Johns Hopkins University focuses on understanding how Aedes aegypti mosquitoes respond to infections by arboviruses like Dengue and Zika. By exploring the immune mechanisms within these mosquitoes, especially through RNA interference and traditional immune pathways, the goal is to develop innovative strategies to reduce the spread of these diseases. This research is particularly important for public health as it can lead to new ways to control mosquito populations and limit virus transmission.

Dr. Xinzhong Dong's lab focuses on understanding chronic itch, a condition that severely impacts patients' lives. They study the role of specific receptors in sensory neurons responsible for itch sensation, especially in response to various diseases and drugs. Their work aims to reveal the biological mechanisms behind itch and facilitate the creation of new treatments for it.

Dr. Yong Du's lab at Johns Hopkins University focuses on developing advanced imaging systems for radiopharmaceutical therapy, a cutting-edge treatment for cancer. They are working to create tools that allow researchers to observe and understand how these therapies target cancer cells at a microscale level, significantly improving the efficacy and safety of treatments. The lab's projects aim to better visualise the distribution and effect of targeted radiation therapies in small animal models and potentially enhance clinical application in humans.

Dr. Richard Edden's lab focuses on using advanced Magnetic Resonance Spectroscopy (MRS) techniques to study brain chemistry throughout different stages of human development, particularly in childhood. The lab develops innovative methods to measure essential neurochemicals non-invasively, which can help investigate brain development and disorders. Their work is closely connected with the Healthy Brain and Child Development Study, aiming to enhance our understanding of neurodevelopmental trajectories and challenges.

Dr. Mikala Egeblad's lab at Johns Hopkins University studies how chronic psychological stress influences cancer metastasis. The research focuses on understanding the biological pathways between the brain and the body that contribute to the spread of cancer, particularly through the activation of stress-related hormones and immune responses. By using mouse models, the lab aims to uncover mechanisms that could eventually lead to better prevention and treatment strategies for metastatic cancers.

Dr. Emily Johnson's research lab at Johns Hopkins University focuses on understanding late-onset epilepsy, particularly how epigenetic factors and chronic health conditions contribute to cognitive decline in older adults. The lab explores the relationship between environmental exposure, genetic markers, and cognitive performance to aid dementia prevention strategies. This work is especially relevant for the over 250,000 older adults in the U.S. suffering from this condition.

Dr. Jill A. Fahrner's lab focuses on understanding the genetic and epigenetic factors that lead to growth and neurodevelopmental disorders in children. They study specific conditions known as Weaver and Sotos syndromes, which are characterized by excessive growth and intellectual disabilities. By using a combination of animal models and human cell models, the lab aims to uncover the underlying mechanisms of these diseases and explore new therapeutic options to improve patient outcomes.

Dr. Mary Glenn Fowler's lab at Johns Hopkins University focuses on HIV research in Uganda, particularly aiming to prevent mother-to-child transmission and improve treatment options for at-risk populations. The lab conducts clinical trials that explore new therapies and vaccines for HIV, while also training the next generation of researchers in these vital areas. Their work addresses a critical public health issue by identifying effective strategies to combat the global HIV pandemic.

Yuan He's lab at Johns Hopkins University studies how cells control gene expression and repair DNA damage. By investigating the processes involved in reading the genome and fixing broken DNA, the lab aims to understand how these actions prevent diseases like cancer. They use advanced imaging and molecular techniques to explore the complex interactions between proteins and DNA that keep our genetic information stable and functioning correctly.

Dr. Gregory A. Newby’s lab at Johns Hopkins University focuses on developing advanced genome editing techniques to treat rare genetic diseases. Their research aims to create versatile tools that can address a wide range of rare genetic variants, making treatment options more accessible for patients. By improving the delivery methods of these genome editing therapies, the lab hopes to enhance their safety and effectiveness.

Dr. Sharon A Nachman's lab at Johns Hopkins University focuses on improving health outcomes for infants, children, adolescents, and pregnant women affected by HIV and tuberculosis. The lab conducts research through the International Maternal Pediatric Adolescent AIDS Clinical Trials Network, exploring safe, effective treatments and strategies to combat HIV and TB in vulnerable populations. Their efforts aim to establish better health interventions and inform public health policies that can help eliminate these epidemics.

Dr. Michael G. Goggins' lab at Johns Hopkins University focuses on improving the early detection and screening of pancreatic cancer, particularly for individuals at high genetic risk. The lab conducts multi-center studies to investigate the efficacy of novel blood tests and imaging techniques in identifying pancreatic cancer at an early stage. Their research aims to enhance patient outcomes through timely diagnosis and surveillance methods.

Dr. David P Goldberg's lab at Johns Hopkins University focuses on studying how certain metal-containing enzymes activate oxygen and oxidize various substrates. By creating synthetic versions of these enzymes, the lab aims to better understand the chemical processes involved in important biological reactions that can impact human health, including those related to diseases like cancer and neurodegenerative disorders.